This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sturgis, E. M. Articles by Wei, Q. Search for Related Content PubMed PubMed Citation Articles by Sturgis, E. M. Articles by Wei, Q.

Alcohol Dehydrogenase 3 Genotype Is Not Associated with Risk of Squamous Cell Carcinoma of the Oral Cavity and Pharynx¹

Departments of Head and Neck Surgery [E. M. S., S. A. E.], and Epidemiology [E. M. S., K. R. D., Y. G., S. S. S., M. R. S., Q. W.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Alcohol is one of the major risk factors for oral and pharyngeal cancer. The rate-limiting step in alcohol metabolism is the oxidation (activation) of ethanol to acetaldehyde by the alcohol dehydrogenases (ADHs). It has been hypothesized that individuals who are homozygous for the fast allele (ADH₃^1–1) are at greater risk for alcohol-related cancers. To test this hypothesis, we investigated the association between the ADH₃ genotype and oral and pharyngeal cancer risk in a large racially homogeneous case-control study of 229 patients and 575 matched control subjects with frequency matching on age, sex, and smoking status. Although the smoking status was matched between cases and controls, current and former alcohol use remained a significant risk factor, compared with never use (odds ratio, 2.08; 95% confidence interval, 1.37–3.17; odds ratio, 1.97; 95% confidence interval, 1.25–3.09; and odds ratio, 1.00, respectively). The ADH₃¹ allele frequency of controls was 57.4%, consistent with reports of similar racial groups (50–60%). The genotype distribution in controls was also consistent with the Hardy-Weinberg equilibrium (P = 0.51). However, the ADH₃¹ allele frequency and ADH₃^1–1 genotype frequency were not significantly different between cases and controls [55.5% versus 57.4% (P = 0.52), and 30.6% versus 31.3% (P = 0.91), respectively]. There was no association between ADH₃ genotypes (ADH₃^1–1, ADH₃^1–2, and ADH₃^2–2) and risk of oral and pharyngeal cancer (odds ratios, 1.00; 0.96; 95% confidence interval, 0.68–1.37; and odds ratio, 1.23; confidence interval, 0.78–1.93, respectively). Therefore, we found no evidence that supports a main effect of ADH₃ genotype or a combined effect of alcohol and ADH₃ genotype on risk of cancer of the oral cavity or pharynx.

This article has been cited by other articles:

				M. Muto, M. Takahashi, A. Ohtsu, S. Ebihara, S. Yoshida, and H. Esumi Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region Carcinogenesis, May 1, 2005; 26(5): 1008 - 1012. [Abstract] [Full Text] [PDF]

				D. Wang, J. M. Ritchie, E. M. Smith, Z. Zhang, L. P. Turek, and T. H. Haugen Alcohol Dehydrogenase 3 and Risk of Squamous Cell Carcinomas of the Head and Neck Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 626 - 632. [Abstract] [Full Text] [PDF]

				J P Visapaa, K Gotte, M Benesova, J Li, N Homann, C Conradt, H Inoue, M Tisch, K Horrmann, S Vakevainen, et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde Gut, June 1, 2004; 53(6): 871 - 876. [Abstract] [Full Text] [PDF]

				G. Poschl and H. K. Seitz ALCOHOL AND CANCER Alcohol Alcohol., May 1, 2004; 39(3): 155 - 165. [Abstract] [Full Text] [PDF]

				P. Brennan Commentary: Mendelian randomization and gene-environment interaction Int. J. Epidemiol., February 1, 2004; 33(1): 17 - 21. [Full Text] [PDF]

				P. Brennan, S. Lewis, M. Hashibe, D. A. Bell, P. Boffetta, C. Bouchardy, N. Caporaso, C. Chen, C. Coutelle, S. R. Diehl, et al. Pooled Analysis of Alcohol Dehydrogenase Genotypes and Head and Neck Cancer: A HuGE Review Am. J. Epidemiol., January 1, 2004; 159(1): 1 - 16. [Abstract] [Full Text] [PDF]

				I. N. Nishimoto, N. A. Pinheiro, S. R. Rogatto, A. L. Carvalho, R. Pereira de Moura, O. L. Caballero, A. Simpson, and L. P. Kowalski Alcohol Dehydrogenase 3 Genotype as a Risk Factor for Upper Aerodigestive Tract Cancers Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 78 - 82. [Abstract] [Full Text] [PDF]

				E. W. Tiemersma, P. A. Wark, M. C. Ocke, A. Bunschoten, M. H. Otten, F. J. Kok, and E. Kampman Alcohol Consumption, Alcohol Dehydrogenase 3 Polymorphism, and Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 419 - 425. [Abstract] [Full Text] [PDF]

				A. Yokoyama and T. Omori Genetic Polymorphisms of Alcohol and Aldehyde Dehydrogenases and Risk for Esophageal and Head and Neck Cancers Jpn. J. Clin. Oncol., March 1, 2003; 33(3): 111 - 121. [Abstract] [Full Text] [PDF]

				A. Yokoyama, H. Kato, T. Yokoyama, T. Tsujinaka, M. Muto, T. Omori, T. Haneda, Y. Kumagai, H. Igaki, M. Yokoyama, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma Carcinogenesis, November 1, 2002; 23(11): 1851 - 1859. [Abstract] [Full Text] [PDF]

				S. M. Schwartz, D. R. Doody, E. D. Fitzgibbons, S. Ricks, P. L. Porter, and C. Chen Oral Squamous Cell Cancer Risk in Relation to Alcohol Consumption and Alcohol Dehydrogenase-3 Genotypes Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1137 - 1144. [Abstract] [Full Text] [PDF]